China Feihe (HKSE:06186) Other Long-Term Liabilities : HK$1,568 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China Feihe Other Long-Term Liabilities?

China Feihe's other long-term liabilities for the quarter that ended in Dec. 2023 was HK$1,568 Mil.

China Feihe's quarterly other long-term liabilities declined from Dec. 2022 (HK$1,779 Mil) to Jun. 2023 (HK$1,541 Mil) but then increased from Jun. 2023 (HK$1,541 Mil) to Dec. 2023 (HK$1,568 Mil).

China Feihe's annual other long-term liabilities increased from Dec. 2021 (HK$1,713 Mil) to Dec. 2022 (HK$1,779 Mil) but then declined from Dec. 2022 (HK$1,779 Mil) to Dec. 2023 (HK$1,568 Mil).

China Feihe Other Long-Term Liabilities Historical Data

The historical data trend for China Feihe's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Feihe Other Long-Term Liabilities Chart

China Feihe Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

China Feihe Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

China Feihe Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

China Feihe Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of China Feihe's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China Feihe (HKSE:06186) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » China Feihe Ltd (HKSE:06186) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

CHFLF:USA CFEIY:USA

Address

10 Jiuxianqiao Road, Block C, 16th Floor, Star City International Building, Chaoyang District, Beijing, CHN, 100016

Website

https://www.feihe.com

Feihe is the number one infant milk formula company in China, with a premium market positioning among domestic and foreign competing brands. The company utilizes the flagship Astrobaby lineup to promote its "more suitable for Chinese babies" proposition. It has a nationwide distributor network covering maternity stores, supermarkets and traditional retailers, as well as a direct sales network in e-commerce.

Executives

Leng Youbin	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Liu Hua	2201 Interest of corporation controlled by you
Liu Shenghui	2201 Interest of corporation controlled by you
Dasheng Limited	2101 Beneficial owner
Leng Youbin	2201 Interest of corporation controlled by you
Garland Glory Holdings Limited	2101 Beneficial owner
Harneys Trustees Limited
Lyb International Holding Limited
Morgan Stanley Private Equity Asia Iii Holdings (cayman) Ltd	2201 Interest of corporation controlled by you
Morgan Stanley Private Equity Asia Iii, Inc.	2201 Interest of corporation controlled by you
Morgan Stanley Private Equity Asia Iii, L.l.c.	2201 Interest of corporation controlled by you
Ms Holdings Incorporated	2201 Interest of corporation controlled by you
North Haven Private Equity Asia Iii, L.p.	2201 Interest of corporation controlled by you
North Haven Private Equity Asia Imf Holding Limited	2101 Beneficial owner

China Feihe (HKSE:06186) Headlines

No Headlines